BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26286143)

  • 1. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin.
    Song L; Xiong D; Kang X; Yang Y; Wang J; Guo Y; Xu H; Chen S; Peng D; Pan Z; Jiao X
    BMC Biotechnol; 2015 Aug; 15():79. PubMed ID: 26286143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    BMC Vet Res; 2017 Jun; 13(1):190. PubMed ID: 28637471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice.
    Song L; Xiong D; Kang X; Jiao Y; Zhou X; Wu K; Zhou Y; Jiao X; Pan Z
    Antiviral Res; 2019 Jan; 161():10-19. PubMed ID: 30389471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HA1-2-fljB Vaccine Induces Immune Responses against Pandemic Swine-Origin H1N1 Influenza Virus in Mice.
    Kang X; Yang Y; Jiao Y; Song H; Song L; Xiong D; Wu L; Pan Z; Jiao X
    J Mol Microbiol Biotechnol; 2016; 26(6):422-432. PubMed ID: 27721310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.
    Song L; Xiong D; Song H; Wu L; Zhang M; Kang X; Pan Z; Jiao X
    Front Immunol; 2017; 8():326. PubMed ID: 28424686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.
    To KK; Zhang AJ; Chan AS; Li C; Cai JP; Lau CC; Li CG; Jahan AS; Wu WL; Li L; Tsang AK; Chan KH; Chen H; Yuen KY
    Arch Virol; 2015 Mar; 160(3):777-86. PubMed ID: 25616843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant HA1-ΔfliC enhances adherence to respiratory epithelial cells and promotes the superiorly protective immune responses against H9N2 influenza virus in chickens.
    Wang T; Wei F; Liu L; Sun Y; Song J; Wang M; Yang J; Li C; Liu J
    Vet Microbiol; 2021 Nov; 262():109238. PubMed ID: 34560407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
    Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
    Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection.
    Kim JH; Hajam IA; Lee JH
    Vet Res; 2018 Feb; 49(1):12. PubMed ID: 29391053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
    Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
    Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W
    Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
    Taylor DN; Treanor JJ; Strout C; Johnson C; Fitzgerald T; Kavita U; Ozer K; Tussey L; Shaw A
    Vaccine; 2011 Jul; 29(31):4897-902. PubMed ID: 21596084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and identification of H5 subtype avian influenza vaccine candidate based on flagellin].
    Wang J; Kang X; Jiao Y; Xiong D; Song L; Yang Y; Pan Z; Jiao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):117-20. PubMed ID: 24491047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Deng L; Kim JR; Chang TZ; Zhang H; Mohan T; Champion JA; Wang BZ
    Virology; 2017 Sep; 509():82-89. PubMed ID: 28622575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.